Collection of Peripheral Blood Mononuclear Cells from Normal Healthy Donors via Apheresis for use in Laboratory Development Studies


About this study

The purpose of this research protocol is to systematically investigate the optimal conditions for isolating and culturing (referred to as manufacturing) of mononuclear cells (MNCs) from healthy volunteers collected via apheresis.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. If you need assistance understanding the eligibility criteria, please contact the study team.

Inclusion Criteria:

  1. Age
    1. Subjects that are ≥18 years old

Exclusion Criteria: 

  1. Disease state
    1. Malignancy
    2. Autoimmune disorders, but not limited to:
      1. Ex Rheumatoid arthritis
      2. Type I diabetes
  2. Adults lacking capacity
  3. Not willing to sign consent form
  4. Medications
    1. Immunomodulatory agents
  5. Infectious disease within 21 days
    1. Any infectious agents regardless of requirements for treatment.


Participating Mayo Clinic locations

Study statuses change often. Please contact us for help.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

Allan Dietz, Ph.D.

Open for enrollment

Contact information:

Karen Krucker


More information


Publications are currently not available

Study Results Summary

Not yet available

Supplemental Study Information

Not yet available


Mayo Clinic Footer